HR 7693

Leo’s Law

Summary

Leo's Law This bill extends by 180 days the relevant periods of market exclusivity for drugs for rare diseases or conditions (i.e., orphan drugs) for which applications were submitted during the COVID-19 emergency period.

Bill status

Status
In committee
Sponsor
Rep. Josh Gottheimer [D-NJ-5]
Cosponsors
1
Policy area
Health
Introduced
2026-02-25
Latest action
2026-02-25: Referred to the House Committee on Energy and Commerce.

Committee referrals

Recent actions

  • 2026-02-25: Referred to the House Committee on Energy and Commerce.
  • 2026-02-25: Introduced in House
  • 2026-02-25: Introduced in House